| This work was supported by a grant from the European Commission (FP7-242209-BIOSTAT-CHF; EudraCT 2010-020808-29). Dr. Metra has received consulting honoraria from Amgen, Bayer, Novartis, and Servier; and speaker fees from Abbott Vascular, Bayer, and ResMed. Dr. Lang has received consultancy fees and/or research grants from Amgen, AstraZeneca, MSD, Novartis, and Servier. Dr. van der Harst has received a research grant from Abbott. Dr. Filippatos has received fees and/or research grants from Novartis, Bayer, Cardiorentis, Vifor, Servier, Alere, and Abbott. Dr. Dickstein has received honoraria and/or research support from Medtronic, Boston Scientific, St. Jude Medical, Biotronik, Sorin, Merck, Novartis, Amgen, Boehringer Ingelheim, AstraZeneca, Pfizer, Bayer, GlaxoSmithKline, Roche, Sanofi, Abbott, Otsuka, Leo, Servier, and Bristol-Myers Squibb. Dr. Cleland has received grant support from Amgen, Novartis, and Stealth Biopharmaceuticals; and honoraria from Servier. Dr. Anker has received grants from Vifor and Abbott Vascular; and consulting fees from Vifor, Bayer, Boehringer Ingelheim, Brahms, Cardiorentis, Janssen, Novartis, Relypsa, Servier, Stealth Peptides, and ZS Pharma. Dr. Voors has received consultancy fees and/or research grants from Alere, Amgen, Bayer, Boehringer Ingelheim, Cardio3Biosciences, Celladon, GlaxoSmithKline, Merck/MSD, Novartis, Servier, Stealth Peptides, Singulex, Sphingotec, Trevena, Vifor, and ZS Pharma. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. |
|
|
